Cargando…
Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis
Autores principales: | Verroken, Alexia, Scohy, Anaïs, Gérard, Ludovic, Wittebole, Xavier, Collienne, Christine, Laterre, Pierre-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347259/ https://www.ncbi.nlm.nih.gov/pubmed/32646494 http://dx.doi.org/10.1186/s13054-020-03135-7 |
Ejemplares similares
-
The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study
por: Verroken, Alexia, et al.
Publicado: (2019) -
Severe Neurological Involvement in an Adult with Shiga Toxin-Producing Escherichia coli-Hemolytic Uremic Syndrome Treated with Eculizumab
por: Vanesse, Pauline, et al.
Publicado: (2023) -
Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis – practical aspects at the bedside and patient identification
por: Laterre, Pierre-François, et al.
Publicado: (2003) -
Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid Effusion
por: Ngougni Pokem, Perrin, et al.
Publicado: (2022) -
Teamwork enables high level of early mobilization in critically ill patients
por: Hickmann, Cheryl Elizabeth, et al.
Publicado: (2016)